Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
29%
OVERLAP
BY WEIGHT
13
# OF OVERLAPPING
HOLDINGS
BBH
27
HOLDINGS
54%
ALSO IN HELX
HELX
67
HOLDINGS
24%
ALSO IN BBH
SECTOR DRIFT (BBH minus HELX)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in BBH |
Weight in HELX |
Overlap | |
|---|---|---|---|---|
 |
NATERA INC | 4.3% | 6.9% | 4.3% |
|
INSMED INC | 4.1% | 4.3% | 4.1% |
|
ALNYLAM PHARMACEUTICALS INC | 4.3% | 3.6% | 3.6% |
|
UNITED THERAPEUTICS CORP | 2.9% | 3.4% | 2.9% |
|
VERTEX PHARMACEUTICALS INC | 9.1% | 2.7% | 2.7% |
BBH Overweight Relative to HELX
|
AMGEN INC | 14.7% |
|
GILEAD SCIENCES INC | 13.9% |
|
VERTEX PHARMACEUTICALS INC | 6.4% |
|
REGENERON PHARMACEUTICALS | 5.5% |
 |
ARGENX SE ADR | 4.3% |
|
IQVIA HOLDINGS INC | 3.8% |
|
BIOGEN IDEC INC | 3.3% |
|
BEIGENE LTD. SPONSORED ADR | 3.2% |
|
ILLUMINA INC | 2.7% |
 |
ICON PLC | 2.4% |
BBH Underweight Relative to HELX
|
GUARDANT HEALTH, INC. | -6.8% |
|
KRYSTAL BIOTECH, INC. | -4.6% |
|
MEDPACE HOLDINGS, INC. | -4.4% |
|
BRIDGEBIO PHARMA, INC. | -3.9% |
|
ADAPTIVE BIOTECHNOLOGIES CORP. | -3.3% |
|
LIGAND PHARMACEUTICALS-CL B | -3.0% |
 |
ASTRAZENECA PLC-SPONS ADR | -2.8% |
|
ELI LILLY & CO | -2.7% |
|
NATERA INC | -2.6% |
|
GENEDX HOLDINGS CORP. CLASS A | -2.3% |